Skip to main content
. 2026 Apr 22;14(4):e7659. doi: 10.1097/GOX.0000000000007659

Table 2.

Baseline Characteristics Before and After Propensity Score Matching

Unmatched Patients Matched Patients
Variable TXA Cohort (N = 1639) Non-TXA (N = 33079) P TXA Cohort (N = 1627) Non-TXA (N = 1627) P
Mean age ± SD 32.8 ± 14.3 32.8 ± 17.5 0.978 32.8 ± 14.3 32.7 ± 14.2 0.816
White, n (%) 1143 (70.0) 22,052 (72.0) 0.087 1141 (70.1) 1144 (70.3) 0.908
Comorbidities, n (%)
 Tobacco use 10 (0.6) 301 (1.0) 0.136 10 (0.6) 10 (0.6) 1.000
 Diabetes mellitus 44 (2.7) 886 (2.9) 0.644 44 (2.7) 42 (2.6) 0.827
 Hypertensive disease 136 (8.3) 3040 (9.9) 0.036* 134 (8.2) 131 (8.1) 0.848
 Other forms of heart disease 65 (4.0) 1376 (4.5) 0.332 65 (4.0) 70 (4.3) 0.660
 Von Willebrand disease 11 (0.7) 32 (0.1) <0.001* 10 (0.6) 10 (0.6) 1.000
 Primary thrombophilia 10 (0.6) 62 (0.2) 0.001* 10 (0.6) 10 (0.6) 1.000
 Coagulation defect, unspecified 10 (0.6) 72 (0.2) 0.003* 10 (0.6) 10 (0.6) 1.000
 Hereditary factor XI deficiency 0 (0.0) 10 (0.0) 0.465 0 (0.0) 0 (0.0)
 Hereditary factor VIII deficiency 10 (0.6) 10 (0.0) <0.001* 10 (0.6) 10 (0.6) 1.000
*

P value less than 0.05, significant results.